Clinical Trials Browser

OTHER × Neuroendocrine Tumors × Doxorubicin × Clear all

NCT01678664 2024-09-25

EVACEL

Phase 2 Completed

74 enrolled 10 charts

Neoplasm Metastasis, Neoplasms, Neuroendocrine Tumors